Skip to main content

ALSUntangled #66: antimycobacterial antibiotics.

Publication ,  Journal Article
Pierce, ES; Barkhaus, P; Beauchamp, M; Bromberg, M; Carter, GT; Goslinga, J; Greeley, D; Kihuwa-Mani, S; Levitsky, G; Lund, I; McDermott, C ...
Published in: Amyotroph Lateral Scler Frontotemporal Degener
August 2023

Several infections have been associated with motor neuron diseases resembling ALS, including species of viruses, bacteria, and parasites. Mycobacterium avium subspecies paratuberculosis (MAP), most known for its probable etiologic association with Crohn's disease, has been suggested as another possible infectious cause of motor neuron disease. Two published case reports describe the successful treatment of ALS-like symptoms with antimycobacterial antibiotics. Both cases had atypical features. Based on these, we believe it would be reasonable to begin performing chest imaging in PALS who have features of their history or exam that are atypical for ALS such as pain, fevers, or eye movement abnormalities. If the chest imaging is abnormal, more specific testing for mycobacteria may be indicated. Until there is more clear evidence of an association between mycobacteria and ALS, we cannot endorse the widespread use of potentially toxic antimycobacterial antibiotics for PALS.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Amyotroph Lateral Scler Frontotemporal Degener

DOI

EISSN

2167-9223

Publication Date

August 2023

Volume

24

Issue

5-6

Start / End Page

539 / 543

Location

England

Related Subject Headings

  • Mycobacterium avium subsp. paratuberculosis
  • Motor Neuron Disease
  • Humans
  • Crohn Disease
  • Anti-Bacterial Agents
  • Animals
  • Amyotrophic Lateral Sclerosis
  • 3209 Neurosciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pierce, E. S., Barkhaus, P., Beauchamp, M., Bromberg, M., Carter, G. T., Goslinga, J., … Bedlack, R. (2023). ALSUntangled #66: antimycobacterial antibiotics. Amyotroph Lateral Scler Frontotemporal Degener, 24(5–6), 539–543. https://doi.org/10.1080/21678421.2022.2104650
Pierce, Ellen S., Paul Barkhaus, Morgan Beauchamp, Mark Bromberg, Gregory T. Carter, Jill Goslinga, David Greeley, et al. “ALSUntangled #66: antimycobacterial antibiotics.Amyotroph Lateral Scler Frontotemporal Degener 24, no. 5–6 (August 2023): 539–43. https://doi.org/10.1080/21678421.2022.2104650.
Pierce ES, Barkhaus P, Beauchamp M, Bromberg M, Carter GT, Goslinga J, et al. ALSUntangled #66: antimycobacterial antibiotics. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Aug;24(5–6):539–43.
Pierce, Ellen S., et al. “ALSUntangled #66: antimycobacterial antibiotics.Amyotroph Lateral Scler Frontotemporal Degener, vol. 24, no. 5–6, Aug. 2023, pp. 539–43. Pubmed, doi:10.1080/21678421.2022.2104650.
Pierce ES, Barkhaus P, Beauchamp M, Bromberg M, Carter GT, Goslinga J, Greeley D, Kihuwa-Mani S, Levitsky G, Lund I, McDermott C, Pattee G, Pierce K, Polak M, Ratner D, Wicks P, Bedlack R. ALSUntangled #66: antimycobacterial antibiotics. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Aug;24(5–6):539–543.

Published In

Amyotroph Lateral Scler Frontotemporal Degener

DOI

EISSN

2167-9223

Publication Date

August 2023

Volume

24

Issue

5-6

Start / End Page

539 / 543

Location

England

Related Subject Headings

  • Mycobacterium avium subsp. paratuberculosis
  • Motor Neuron Disease
  • Humans
  • Crohn Disease
  • Anti-Bacterial Agents
  • Animals
  • Amyotrophic Lateral Sclerosis
  • 3209 Neurosciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences